BlackRock Fund Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $28.9M | Buy |
1,398,009
+80,278
| +6% | +$1.66M | 0.01% | 1980 |
|
|
2016
Q3 | $21.4M | Buy |
1,317,731
+123,376
| +10% | +$2M | ﹤0.01% | 2034 |
|
|
2016
Q2 | $16.2M | Buy |
1,194,355
+43,856
| +4% | +$596K | ﹤0.01% | 2144 |
|
|
2016
Q1 | $20.1M | Buy |
1,150,499
+100,774
| +10% | +$1.76M | ﹤0.01% | 1990 |
|
|
2015
Q4 | $35.9M | Buy |
1,049,725
+296,761
| +39% | +$10.1M | 0.01% | 1705 |
|
|
2015
Q3 | $22.4M | Buy |
752,964
+31,965
| +4% | +$951K | 0.01% | 1923 |
|
|
2015
Q2 | $23.1M | Buy |
720,999
+179,272
| +33% | +$5.73M | 0.01% | 2025 |
|
|
2015
Q1 | $11.2M | Buy |
541,727
+26,135
| +5% | +$542K | ﹤0.01% | 2379 |
|
|
2014
Q4 | $8.73M | Buy |
515,592
+313,956
| +156% | +$5.32M | ﹤0.01% | 2540 |
|
|
2014
Q3 | $3.9M | Buy |
201,636
+25,322
| +14% | +$490K | ﹤0.01% | 2883 |
|
|
2014
Q2 | $6M | Sell |
176,314
-13,433
| -7% | -$457K | ﹤0.01% | 2735 |
|
|
2014
Q1 | $5.98M | Buy |
+189,747
| New | +$5.98M | ﹤0.01% | 2712 |
|